PuSH - Publication Server of Helmholtz Zentrum München

Crystal structure of the RNA-recognition motif of Drosophila melanogaster tRNA (uracil-5-)-methyltransferase homolog A.

Acta Crystallogr. F-Struct. Biol. Cryst. Commun. 80, 36-42 (2024)
Publ. Version/Full Text DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
Human tRNA (uracil-5-)-methyltransferase 2 homolog A (TRMT2A) is the dedicated enzyme for the methylation of uridine 54 in transfer RNA (tRNA). Human TRMT2A has also been described as a modifier of polyglutamine (polyQ)-derived neuronal toxicity. The corresponding human polyQ pathologies include Huntington's disease and constitute a family of devastating neurodegenerative diseases. A polyQ tract in the corresponding disease-linked protein causes neuronal death and symptoms such as impaired motor function, as well as cognitive impairment. In polyQ disease models, silencing of TRMT2A reduced polyQ-associated cell death and polyQ protein aggregation, suggesting this protein as a valid drug target against this class of disorders. In this paper, the 1.6 Å resolution crystal structure of the RNA-recognition motif (RRM) from Drosophila melanogaster, which is a homolog of human TRMT2A, is described and analysed.
Impact Factor
Scopus SNIP
Altmetric
1.100
0.000
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Drosophila Melanogaster ; Rrms ; Trmt2a ; X-ray Crystallography ; Methyltransferases ; Neurodegenerative Disease; Complex Reveals; Binding; Domain; Specificity; Tdp-43; Tool
Language english
Publication Year 2024
HGF-reported in Year 2024
e-ISSN 2053-230X
Quellenangaben Volume: 80, Issue: , Pages: 36-42 Article Number: , Supplement: ,
Publisher Blackwell
Publishing Place Oxford [u.a.]
Reviewing status Peer reviewed
POF-Topic(s) 30203 - Molecular Targets and Therapies
Research field(s) Enabling and Novel Technologies
PSP Element(s) G-503091-001
Grants BMBF
Scopus ID 85184139625
PubMed ID 38270511
Erfassungsdatum 2024-04-17